Bioharvest Sciences (BHST) | Stock Overview & Key Data
Bioharvest Sciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $12.80 on October 7, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bioharvest Sciences
BHST
|
99.29M Micro-cap | -7.42% | -12.56% | -19.73% | -42.81% | -30.52% | -38.34% | -35.67% | -35.67% | -35.67% | -35.67% | -35.67% |
| 29.03B Large-cap | 0.35% | 0.14% | 4.85% | 2.24% | 2.20% | 3.57% | 24.65% | 43.15% | 25.55% | 73.47% | 99.09% | |
|
Kraft Heinz
KHC
|
26.01B Large-cap | -2.14% | 4.10% | -4.77% | -6.49% | -4.31% | -10.18% | -37.65% | -45.38% | -71.85% | -29.59% | -16.52% |
|
BRC
BRCC
|
129.29M Micro-cap | -10.86% | 43.12% | 143.75% | 21.88% | 39.29% | -8.38% | -70.13% | -89.93% | -89.93% | -89.93% | -89.93% |
|
FitLife Brands
FTLF
|
90.15M Micro-cap | -2.11% | 0.73% | -35.54% | -45.02% | -38.32% | -30.19% | 27.75% | 127.11% | 5,577.78% | 10,120.00% | 426.80% |
|
DDC Enterprise
DDC
|
80.58M Micro-cap | 5.83% | -20.63% | -44.54% | -58.77% | -39.81% | -81.41% | -99.07% | -99.07% | -99.07% | -99.07% | -99.07% |
Ownership & Short Interest
Calculate Your Bioharvest Sciences Investment Returns
Long-Term Investment Performance Analysis
Bioharvest Sciences stock price in Nov 2024 was $6.00, A $1,000.00 lump sum investment in Bioharvest Sciences made 1 years ago would be worth approximately $593.33 today, representing a negative return of -40.67%. This translates to an annualized return (CAGR) of -28.47%.
1 Year 6 Months Investment Scenario (Nov 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BHST's 52-week high and low?
- In the last 52 weeks, Bioharvest Sciences reached a high of $12.80 (on October 8, 2025) and a low of $3.54 (on June 3, 2026).
- What is the market cap and P/E ratio for BHST?
- Curious about Bioharvest Sciences's size and valuation? Its market capitalization stands at 99.29M. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.30, and the forward P/E (looking ahead) is -51.53.
- Does BHST pay dividends? If so, what's the yield?
- As for dividends, Bioharvest Sciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Bioharvest Sciences's main competitors or similar companies to consider before investing?
When looking at Bioharvest Sciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Kellanova
K29.03B Consumer Defensive Packaged Foods 3.57% 24.65% Kraft Heinz
KHC26.01B Consumer Defensive Packaged Foods -10.18% -37.65% BRC
BRCC129.29M Consumer Defensive Packaged Foods -8.38% -70.13% FitLife Brands
FTLF90.15M Consumer Defensive Packaged Foods -30.19% 27.75% DDC Enterprise
DDC80.58M Consumer Defensive Packaged Foods -81.41% -99.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bioharvest Sciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Bioharvest Sciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -83.17%, the Debt to Equity ratio from the most recent quarter is 55.42, and its Gross Profit Margin stands at 57.63%.
- What is the recent revenue and earnings growth for BHST?
- Looking at Bioharvest Sciences's growth, its revenue over the trailing twelve months (TTM) was $35M. Compared to the same quarter last year (YoY), quarterly revenue grew by 24.60%, and quarterly earnings saw a YoY growth of 24.57%.
- How much of BHST stock is held by insiders and institutions?
- Wondering who owns Bioharvest Sciences stock? Company insiders (like executives and directors) hold about 16.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.28%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.